BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Z, Zhang F, Ma W, Chen B, Zhou F, Xu Z, Zhang Y, Zhang D, Zhu T, Wang L. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery. Cardiovasc Ther. 2010;28:380-385. [PMID: 20337639 DOI: 10.1111/j.1755-5922.2009.00116.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nernpermpisooth N, Sarre C, Barrere C, Contreras R, Luz-Crawford P, Tejedor G, Vincent A, Piot C, Kumphune S, Nargeot J, Jorgensen C, Barrère-Lemaire S, Djouad F. PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury. Front Cardiovasc Med 2021;8:681002. [PMID: 34616778 DOI: 10.3389/fcvm.2021.681002] [Reference Citation Analysis]
2 Ichim TE, O'Heeron P, Kesari S. Fibroblasts as a practical alternative to mesenchymal stem cells. J Transl Med 2018;16:212. [PMID: 30053821 DOI: 10.1186/s12967-018-1536-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
3 Hervy M, Weber JL, Pecheul M, Dolley-Sonneville P, Henry D, Zhou Y, Melkoumian Z. Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions. PLoS One 2014;9:e92120. [PMID: 24638103 DOI: 10.1371/journal.pone.0092120] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
4 Amato B, Compagna R, Amato M, Grande R, Butrico L, Rossi A, Naso A, Ruggiero M, de Franciscis S, Serra R. Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms. Stem Cells Int 2015;2015:434962. [PMID: 25866513 DOI: 10.1155/2015/434962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
5 Narita T, Suzuki K. Bone marrow-derived mesenchymal stem cells for the treatment of heart failure. Heart Fail Rev. 2015;20:53-68. [PMID: 24862087 DOI: 10.1007/s10741-014-9435-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
6 Chen J, Li C, Gao X, Li C, Liang Z, Yu L, Li Y, Xiao X, Chen L. Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice. PLoS One 2013;8:e83303. [PMID: 24367590 DOI: 10.1371/journal.pone.0083303] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
7 Liu Y, Tse HF. The proarrhythmic risk of cell therapy for cardiovascular diseases. Expert Rev Cardiovasc Ther 2011;9:1593-601. [PMID: 22103878 DOI: 10.1586/erc.11.171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Fisher SA, Zhang H, Doree C, Mathur A, Martin-rendon E; Cochrane Heart Group. Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd006536.pub4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
9 Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ;  Canadian Critical Care Trials Group. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7:e47559. [PMID: 23133515 DOI: 10.1371/journal.pone.0047559] [Cited by in Crossref: 671] [Cited by in F6Publishing: 631] [Article Influence: 67.1] [Reference Citation Analysis]
10 Takafuji Y, Hori M, Mizuno T, Harada-Shiba M. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice. Cardiovasc Res 2019;115:1041-51. [PMID: 30388208 DOI: 10.1093/cvr/cvy271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
11 Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28:387-402. [PMID: 23864795 DOI: 10.3904/kjim.2013.28.4.387] [Cited by in Crossref: 165] [Cited by in F6Publishing: 155] [Article Influence: 18.3] [Reference Citation Analysis]
12 Müller P, Gaebel R, Lemcke H, Wiekhorst F, Hausburg F, Lang C, Zarniko N, Westphal B, Steinhoff G, David R. Intramyocardial fate and effect of iron nanoparticles co-injected with MACS® purified stem cell products. Biomaterials 2017;135:74-84. [PMID: 28494265 DOI: 10.1016/j.biomaterials.2017.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
13 Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011;22:3-17. [PMID: 21062128 DOI: 10.1089/hum.2010.211] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 8.6] [Reference Citation Analysis]
14 Teng M, Geng Z, Huang L, Zhao X. Stem cell transplantation in cardiovascular disease: an update. J Int Med Res 2012;40:833-8. [PMID: 22906255 DOI: 10.1177/147323001204000301] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int 2017;2017:8506370. [PMID: 29056973 DOI: 10.1155/2017/8506370] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
16 Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54:1418-1437. [PMID: 24898458 DOI: 10.1111/trf.12421] [Cited by in Crossref: 259] [Cited by in F6Publishing: 254] [Article Influence: 28.8] [Reference Citation Analysis]
17 Pooria A, Pourya A, Gheini A. Animal- and human-based evidence for the protective effects of stem cell therapy against cardiovascular disorders. J Cell Physiol 2019. [PMID: 30811030 DOI: 10.1002/jcp.28330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lalu MM, Mazzarello S, Zlepnig J, Dong YYR, Montroy J, McIntyre L, Devereaux PJ, Stewart DJ, David Mazer C, Barron CC, McIsaac DI, Fergusson DA. Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis. Stem Cells Transl Med. 2018;7:857-866. [PMID: 30255989 DOI: 10.1002/sctm.18-0120] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
19 Vandermeulen M, Grégoire C, Briquet A, Lechanteur C, Beguin Y, Detry O. Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World J Gastroenterol 2014; 20(44): 16418-16432 [PMID: 25469010 DOI: 10.3748/wjg.v20.i44.16418] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
20 Yan XZ, van den Beucken JJ, Both SK, Yang PS, Jansen JA, Yang F. Biomaterial strategies for stem cell maintenance during in vitro expansion. Tissue Eng Part B Rev 2014;20:340-54. [PMID: 24168361 DOI: 10.1089/ten.TEB.2013.0349] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
21 Qazi RE, Naeem N, Khan I, Qadeer Q, Shaheen F, Salim A. Effect of a dianthin G analogue in the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes. Mol Cell Biochem 2020;475:27-39. [PMID: 32737770 DOI: 10.1007/s11010-020-03855-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ghiroldi A, Piccoli M, Cirillo F, Monasky MM, Ciconte G, Pappone C, Anastasia L. Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies. Int J Mol Sci 2018;19:E3194. [PMID: 30332812 DOI: 10.3390/ijms19103194] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
23 Lopes JP, Fiarresga A, Silva Cunha P, Feliciano J, Cruz Ferreira R. [Mesenchymal stem cell therapy in heart disease]. Rev Port Cardiol 2013;32:43-7. [PMID: 23183241 DOI: 10.1016/j.repc.2012.05.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
24 Sattayaprasert P, Nassal DM, Wan X, Deschenes I, Laurita KR. Mesenchymal stem cells suppress cardiac alternans by activation of PI3K mediated nitroso-redox pathway. J Mol Cell Cardiol 2016;98:138-45. [PMID: 27238412 DOI: 10.1016/j.yjmcc.2016.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Rocca A, Tafuri D, Paccone M, Giuliani A, Zamboli AGI, Surfaro G, Paccone A, Compagna R, Amato M, Serra R, Amato B. Cell Based Therapeutic Approach in Vascular Surgery: Application and Review. Open Med (Wars) 2017;12:308-22. [PMID: 29071303 DOI: 10.1515/med-2017-0045] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Kastrup J, Mygind ND, Qayyum AA, Mathiasen AB, Haack-sørensen M, Ekblond A. Mesenchymal stromal cell therapy in ischemic heart disease. Scandinavian Cardiovascular Journal 2016;50:293-9. [DOI: 10.1080/14017431.2016.1210213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
27 Gorabi AM, Tafti SHA, Soleimani M, Panahi Y, Sahebkar A. Cells, Scaffolds and Their Interactions in Myocardial Tissue Regeneration: C ELLS , S CAFFOLDSAND T HEIR I NTERACTIONS. J Cell Biochem 2017;118:2454-62. [DOI: 10.1002/jcb.25912] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
28 Gökçinar-yagci B, Çelebi-saltik B. Comparison of different culture conditions for smooth muscle cell differentiation of human umbilical cord vein CD146+ perivascular cells. Cell Tissue Bank 2017;18:501-11. [DOI: 10.1007/s10561-017-9656-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Zhang Y, Liang X, Lian Q, Tse HF. Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration. Expert Rev Cardiovasc Ther 2013;11:505-17. [PMID: 23570363 DOI: 10.1586/erc.13.5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
30 Minguell JJ, Allers C, Lasala GP. Mesenchymal stem cells and the treatment of conditions and diseases: the less glittering side of a conspicuous stem cell for basic research. Stem Cells Dev 2013;22:193-203. [PMID: 23025629 DOI: 10.1089/scd.2012.0417] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
31 Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12:260. [PMID: 25304688 DOI: 10.1186/s12967-014-0260-8] [Cited by in Crossref: 285] [Cited by in F6Publishing: 276] [Article Influence: 35.6] [Reference Citation Analysis]
32 Zhao C, Lin K, Wang X. Maintenance and modulation of stem cells stemness based on biomaterial designing via chemical and physical signals. Applied Materials Today 2020;19:100614. [DOI: 10.1016/j.apmt.2020.100614] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
33 Chu X, Xu B, Gao H, Li BY, Liu Y, Reiter JL, Wang Y. Lipopolysaccharides Improve Mesenchymal Stem Cell-Mediated Cardioprotection by MyD88 and stat3 Signaling in a Mouse Model of Cardiac Ischemia/Reperfusion Injury. Stem Cells Dev 2019;28:620-31. [PMID: 30808255 DOI: 10.1089/scd.2018.0213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
34 Park BN, Shim W, Ahn YH, Lee JH, An YS, Yoon JK. High-dose (111)in induces g1 cell cycle arrest and cell death in rat bone marrow mesenchymal stem cells. Nucl Med Mol Imaging 2012;46:81-8. [PMID: 24900039 DOI: 10.1007/s13139-011-0124-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Ellison-Hughes GM, Colley L, O'Brien KA, Roberts KA, Agbaedeng TA, Ross MD. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.Front Cardiovasc Med. 2020;7:602183. [PMID: 33363221 DOI: 10.3389/fcvm.2020.602183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Saraswati S, Guo Y, Atkinson J, Young PP. Prolonged hypoxia induces monocarboxylate transporter-4 expression in mesenchymal stem cells resulting in a secretome that is deleterious to cardiovascular repair. Stem Cells 2015;33:1333-44. [PMID: 25537659 DOI: 10.1002/stem.1935] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
37 Knyazev OV, Parfenov AI, Konoplyannikov AG, Ruchkina IN, Churikova AA, Bykova SV, Albulova EA, Boldyreva ON, Fadeeva NA, Lishchinskaya AA. [Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up]. Ter Arkh 2015;87:39-44. [PMID: 25864347 DOI: 10.17116/terarkh201587239-44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
38 Richardson JD, Nelson AJ, Zannettino AC, Gronthos S, Worthley SG, Psaltis PJ. Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Rev Rep 2013;9:281-302. [PMID: 22529015 DOI: 10.1007/s12015-012-9366-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]